SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Dermata (DRMAW) opens preorders for Tome treatment

Dermata announces preorders are now open for its Tome foundational treatment ahead of its commercial launch, with no additional financial figures or pricing details provided in the feed.

DRMAW

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.